With deCODE genetics, Inc. (DCGN) Deal, Amgen (AMGN) Aims to Discover Drugs Like We Meant to in 1999
12/11/2012 8:50:21 AM
More...
|
Amgen (AMGN) Bags Gene-Hunting Firm deCODE genetics, Inc. (DCGN) for $415 Million Cash
12/10/2012 8:22:40 AM
More...
|
deCODE genetics, Inc. (DCGN), Multinational Research Team Find Gene Variant Conferring High Risk for Common, Late-Onset Form of Alzheimer's Disease
11/15/2012 9:46:59 AM
More...
|
New Gene Triples Risk for Alzheimer's Disease, deCODE genetics, Inc. (DCGN) and University College London Study
11/15/2012 6:17:55 AM
More...
|
Older Dads Linked to Rise in Genetic Disorder, deCODE genetics, Inc. (DCGN) Reveals
8/23/2012 7:38:49 AM
More...
|
Genentech (RHHBY), deCODE genetics, Inc. (DCGN) Identify Protective Gene Against Alzheimer's, Cognitive Decline
7/12/2012 6:53:46 AM
More...
|
deCODE genetics, Inc. (DCGN), in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
1/23/2012 10:06:15 AM
More...
|
deCODE genetics, Inc. (DCGN) Announces Agreement With Pfizer Inc. (PFE) to Search for Variants in the Human Genome That Confer Risk of Systemic Lupus Erythematosis
10/12/2011 11:59:43 AM
More...
|
deCODE genetics, Inc. (DCGN), in Collaboration with Academic Colleagues and Illumina, Inc. (ILMN), Discovers Two Rare Variants that Affect the Risk of Gout and Serum Uric Acid Levels
10/10/2011 11:30:55 AM
More...
|
deCODE genetics, Inc. (DCGN), in Collaboration with Academic Colleagues and Illumina, Inc. (ILMN), Discovers Mutations Conferring High Risk of Ovarian Cancer
10/3/2011 10:34:22 AM
More...
|
|